Merger activity sizzles in the food business, Apple experiments with Beats, and Pfizer stays disciplined.
With roughly two thirds of this sector enjoying a narrow or wide economic moat, we continue to find pockets of opportunity when short-term concerns outweigh our forecasted long-term growth trajectories.
Three stocks we think investors should be wary of.
A bidding war is sizzling for this meat-centric firm, but Tyson is grazing dangerous terrain.
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
Pilgrim's Pride is having a difficult time navigating a slumping export market for its product.